John L. Higgins

2017

In 2017, John L. Higgins earned a total compensation of $5.5M as Chief Executive Officer at Ligand Pharmaceuticals, a 3% increase compared to previous year.

Compensation breakdown

Bonus$30,000
Non-Equity Incentive Plan$550,491
Option Awards$2,202,412
Salary$611,656
Stock Awards$2,111,154
Other$7,494
Total$5,513,207

Higgins received $2.2M in option awards, accounting for 40% of the total pay in 2017.

Higgins also received $30K in bonus, $550.5K in non-equity incentive plan, $611.7K in salary, $2.1M in stock awards and $7.5K in other compensation.

Rankings

In 2017, John L. Higgins' compensation ranked 1,649th out of 14,666 executives tracked by ExecPay. In other words, Higgins earned more than 88.8% of executives.

ClassificationRankingPercentile
All
1,649
out of 14,666
89th
Division
Manufacturing
555
out of 5,768
90th
Major group
Chemicals And Allied Products
147
out of 2,074
93rd
Industry group
Drugs
107
out of 1,730
94th
Industry
Pharmaceutical Preparations
85
out of 1,329
94th
Source: SEC filing on April 30, 2018.

Higgins' colleagues

We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2017.

2017

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2017

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

2017

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

You may also like